ArticleMicrobiology spectrum2025
Comparative evaluation of long-term preservation methods for morphologically distinct bacteriophages.
Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Strain-level molecular and infection traits are associated with differences in phage efficacy against Pseudomonas aeruginosa.Scientific reports · 2026Article
- Wood Hemicellulose-Based Spray-Dried Microencapsulation of a Lytic Bacteriophage Preserves Phage Viability and Improves Control of the Bacterial Wilt Pathogen Ralstonia solanacearum.Microbial biotechnology · 2026Article
- Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review.Frontiers in microbiology · 2026Review
- Characterization of a newly isolated broad-host-range lytic phage WEN7 against multidrug-resistant clinicalFrontiers in microbiology · 2026Article
- Engineered Phage-Guided Nanotherapeutic Systems for Precision Antibacterial Therapy: Hacking Bacterial Resistance Mechanisms.Pharmaceutics · 2025Review
- Characterization and Genome Comparison of Bacteriophage KKU62-1 Infecting Hypervirulent Streptococcus agalactiae ST283.Current microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rapid increase in antibiotic resistance has led to a renewed interest in phage therapy, which has created a need for the establishment of phage collections in order to preserve diverse phages and to reduce the delivery time to patients. However, there are currently no standard methods for the long-term preservation of phages. We assessed the stability of four different phages under distinct storage conditions, including different temperatures, storage solutions, concentrations, and with or without cryoprotectant. We found that the type of storage buffer has a significant impact on phage stability, followed by the storage temperature. Phages demonstrated higher viability in lysogeny broth (LB) than saline-magnesium (SM) buffer without gelatin. We also observed a higher sensitivity to freezing in tailed phages with longer tails, such as T4. Ultimately, we found that all four phages maintained high stability after snap freezing, followed by storage at -80°C using LB as a storage buffer without cryoprotectant. IMPORTANCE: Phage therapy, which involves treating bacterial infections using bacteriophages (phage), has shown promise as an alternative to antibiotics and can offer a solution for treating infections caused by antibiotic-resistant bacteria. However, phages are not conventional drugs and can lose their viability when stored under unsuitable conditions. Their high diversity makes finding a standard storage method for long-term preservation challenging. Here, we studied the stability of phages under different storage conditions and identified key factors affecting their viability. We have also identified a specific storage condition that can effectively preserve a wide range of phage morphotypes for over 2 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.